Biotech firm Avacta Group PLC (LON:AVCT) is to raise £9mln to push ahead with a first clinical trial of anti-cancer treatment Pro-Doxorubicin.

APQ Global PLC (LON:APQ) ended the third quarter with “fairly defensive positioning” but is on track to meet its target annual dividend yield of 6%.

Amphion Innovations PLC (LON:AMP) has received confirmation that the sale of its stake in medical imaging group Polarean settled its loan facility with no outstanding obligations to the lender. The sale raised US$2.6mln. Shares in Amphion remain suspended with the group still describing itself as ‘highly cash constrained’.

Live Company Group PLC (LON:LVCG) is still in advanced discussions with the sellers of Bright Bricks Holdings about the deferred consideration for the acquisition.

Curzon Energy PLC (LON:CZN) told investors it has agreed to refinance £200,000 of secured loan notes.

Thor Mining PLC (LON:THR) has confirmed plans for an equity fundraise and will announce the details in due course.

Directa Plus PLC (LON:DCTA) has raised gross proceeds of roughly £0.2mln through an open offer and £7.4mln through the placing and open offer, before expenses. Between them, six directors bought £303,656 worth of shares, mostly founder and CEO Giulio Cesareo.

Remote Monitored Systems (LON:RMS) has raised £250,000 in a placing to support the continuing growth of GyroMetric, to develop its new Intelligence & Security division, and to settle creditors and provide working capital. Directors Trevor Brown and Paul Ryan contributed £112,500 of the total.

Galileo Resources PLC (LON:GLR) completed a placing with institutional and retail investors to raise £500,000 before expenses. The proceeds will be used for general working capital towards advancing its Star Zinc and Kashitu projects in Zambia, including an application and related environmental and licence transfer activities for a small-scale mining permit for Star Zinc and exploration on Kashitu.